C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1997
11/04/1997	US5683903 Attachment enhanced 293 cells
11/04/1997	US5683901 Method of producing RNA viruses from cDNA
11/04/1997	US5683900 Pasteurella haemolytica PhaI restriction endonuclcape and methyltranstesase
11/04/1997	US5683899 Methods and compositions for combinatorial-based discovery of new multimeric molecules
11/04/1997	US5683894 Recombinant nerve growth factor
11/04/1997	US5683893 Mutant AOX2 promoter, vector carrying same, transformant, and production of heterlogous protein
11/04/1997	US5683890 Bacteriocins from Streptococcus thermophilus
11/04/1997	US5683888 Modified bioluminescent proteins and their use
11/04/1997	US5683887 Immunochemical detection of in vivo advanced glycosylation endproducts
11/04/1997	US5683886 Tumor rejection antigens which correspond to amino acid sequences in tumor rejection antigen precursor bage, and uses thereof
11/04/1997	US5683884 Incubation of eukarotic cells with transformed or transfected with dna sequences for gene expression
11/04/1997	US5683878 Medical diagnosis using dna and rna and transcription
11/04/1997	US5683864 Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
11/04/1997	US5683701 Peptide fragments of HIV
11/04/1997	US5683700 Immunization using an attenuated salmonella bacterium containing an nirb promoter linked to a dna sequence encoding a heterologous protein
11/04/1997	US5683696 Cloning of duffy blood group antigen, gpD
11/04/1997	US5683695 Production of recombinant proteins containing multiple antigenic determinants linked by flexible hinge domains
11/04/1997	US5683693 Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
11/04/1997	US5683688 Unglycosylated recombinant human lymphotoxin polypeptides and compositions
11/04/1997	US5683674 Antibody against human mucin core protein and method of preparing and using same
11/04/1997	CA1339526C Recombinant myco-bacterial expression vehicles and uses therefor
10/1997
10/31/1997	CA2175435A1 Proteins involved in the synthesis and assembly of o-antigen in pseudomonas aeruginosa
10/30/1997	WO1997040388A1 Peptides having specific affinity to pacap type 1 receptors
10/30/1997	WO1997040380A1 Leptin assay
10/30/1997	WO1997040192A1 Novel protein - traf6
10/30/1997	WO1997040186A1 Detection of variations in human h2 receptors
10/30/1997	WO1997040182A1 Genetically transfected human dendritic cells, their production and use, preferably as vaccines
10/30/1997	WO1997040180A1 Chicken embryo lethal orphan (celo) virus
10/30/1997	WO1997040178A1 Monitoring of transgenic plants with in vivo markers
10/30/1997	WO1997040177A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
10/30/1997	WO1997040168A1 Hepatitis g virus protease
10/30/1997	WO1997040167A1 Porcine retrovirus
10/30/1997	WO1997040166A2 Simian-human hav having a chimeric 2c protein
10/30/1997	WO1997040165A1 Novel human cytomegalovirus dna constructs and uses therefor
10/30/1997	WO1997040164A1 Hepatitis b monoclonal antibodies
10/30/1997	WO1997040163A1 Nucleic acid vaccination for parvoviral infections
10/30/1997	WO1997040162A2 Pesticidal toxins
10/30/1997	WO1997040161A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
10/30/1997	WO1997040160A1 A prokaryotic protein having functional and structural homology with the human p-glycoprotein encoded by the mdr-1 gene, nucleic acids encoding and cells expressing said protein
10/30/1997	WO1997040159A1 Characterization of transfer factors and methods of use
10/30/1997	WO1997040158A1 Epimorphin antagonist and process for producing the same
10/30/1997	WO1997040156A1 Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes
10/30/1997	WO1997040155A1 Protein mediating neuronal-glial interaction, dna encoding the same, and methods of use thereof
10/30/1997	WO1997040154A1 Type c lectins
10/30/1997	WO1997040153A1 Al-2 neurotrophic factor
10/30/1997	WO1997040152A1 Glial cell line-derived neurotrophic factor receptor
10/30/1997	WO1997040151A2 Secreted proteins and polynucleotides encoding them
10/30/1997	WO1997040150A1 Novel proteins c16 and c16n or genes encoding the same
10/30/1997	WO1997040149A1 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
10/30/1997	WO1997040148A2 Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors
10/30/1997	WO1997040147A1 Antigenically reactive regions of the hepatitis a virus polyprotein
10/30/1997	WO1997040145A1 Inactivation resistant factor viii
10/30/1997	WO1997040143A1 Apoptosis inducing protein and gene encoding the same
10/30/1997	WO1997040142A1 Modified ligands of calcium-dependent binding proteins
10/30/1997	WO1997040141A2 Isolation of enzymes
10/30/1997	WO1997040138A1 Thrombin receptor modified transgenic animals
10/30/1997	WO1997040073A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS
10/30/1997	WO1997040072A2 Adam proteins and uses thereof
10/30/1997	WO1997040071A1 Compounds with growth hormone releasing properties
10/30/1997	WO1997040070A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
10/30/1997	WO1997040069A2 Secreted proteins and polynucleotides encoding them
10/30/1997	WO1997040068A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
10/30/1997	WO1997040064A1 Human netrin-1
10/30/1997	WO1997040063A2 Pathogenic escherichia coli associated protein espa
10/30/1997	WO1997040059A1 Tumor suppressor gene
10/30/1997	WO1997040058A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997	WO1997039766A1 Regulation of cellular volume via chloride conductive polypeptide channels
10/30/1997	WO1997039765A1 Component b as cicatrizant
10/30/1997	WO1997039761A1 A process for viral inactivation of lyophilized blood proteins
10/30/1997	WO1997039722A2 Method of isolating regulators of t cell activation
10/30/1997	WO1997039721A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997	WO1997039623A2 Improved production of insecticidal proteins
10/30/1997	WO1997035997A3 Recombinant pox virus encoding myelin protein for therapy
10/30/1997	WO1997035878A3 The porcine heart fatty acid-binding protein encoding gene and methods to identify polymorphisms associated with body weight
10/30/1997	WO1997035021A3 Prostate specific antigen oligo-epitope peptide
10/30/1997	WO1997025426A3 Compositions and methods for the treatment and diagnosis of breast cancer
10/30/1997	WO1997006255A3 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
10/30/1997	CA2253249A1 Novel proteins c16 and c16n or genes encoding the same
10/30/1997	CA2252835A1 Chicken embryo lethal orphan (celo) virus
10/30/1997	CA2252643A1 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997	CA2252626A1 Thrombin receptor modified transgenic animals
10/30/1997	CA2252581A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997	CA2252458A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
10/30/1997	CA2252443A1 Leptin assay
10/30/1997	CA2252439A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
10/30/1997	CA2252369A1 Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors
10/30/1997	CA2252088A1 Secreted proteins and polynucleotides encoding them
10/30/1997	CA2251977A1 Antigenically reactive regions of the hepatitis a virus polyprotein
10/30/1997	CA2251943A1 Characterization of transfer factors and methods of use
10/30/1997	CA2251939A1 Porcine retrovirus
10/30/1997	CA2251934A1 Secreted proteins and polynucleotides encoding them
10/30/1997	CA2251832A1 Simian-human hav having a chimeric 2c protein
10/30/1997	CA2251727A1 Regulation of cellular volume via chloride conductive polypeptide channels
10/30/1997	CA2251680A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
10/30/1997	CA2251584A1 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
10/30/1997	CA2251356A1 Component b as cicatrizant
10/30/1997	CA2250966A1 Monitoring of transgenic plants with in vivo markers
10/30/1997	CA2250922A1 Isolation of enzymes
10/30/1997	CA2250921A1 Modified ligands of calcium-dependent binding proteins
10/30/1997	CA2250431A1 Al-2 neurotrophic factor

1 ... 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 ... 2916